Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 23 January 2026

Life360 stock jumps 22% as record Q4 user growth lifts outlook ahead of March results

Life360 stock jumps 22% as record Q4 user growth lifts outlook ahead of March results

Life360 shares jumped 22% Friday after the company reported record Q4 user and subscriber growth and raised its 2025 revenue and adjusted EBITDA forecasts. The stock reached $66.90 in afternoon trading, up $12.09. Global monthly active users rose to 95.8 million, with 2.8 million paying circles. Full-year results and 2026 guidance are set for release March 2.
23 January 2026
····
Applied Digital (APLD) stock jumps on 430-MW Delta Forge AI campus build; location due in February

Applied Digital (APLD) stock jumps on 430-MW Delta Forge AI campus build; location due in February

Applied Digital shares rose 9.8% to $38.13 Friday after the company announced it broke ground on a new AI data center campus, Delta Forge 1, in the southern U.S. The facility targets 430 MW of utility power and aims to start operations by mid-2027. Investors pressed for tenant and location details; the CEO said the site will be revealed in February. No tenants have been named.
23 January 2026
·····
PepsiCo stock slips even as Coca-Cola rises; traders eye Feb. 3 earnings

PepsiCo stock slips even as Coca-Cola rises; traders eye Feb. 3 earnings

PepsiCo shares slipped 0.2% to $144.05 Friday, trailing gains in Coca-Cola and Mondelez, as the consumer staples sector edged higher. The stock remains about 10% below its 52-week high after a 1.6% drop Thursday. Investors are watching next week’s Federal Reserve decision and PepsiCo’s Feb. 3 earnings report for direction.
23 January 2026
······
B2Gold stock price today: BTG edges up as gold nears $5,000 and Feb. 18 earnings loom

B2Gold stock price today: BTG edges up as gold nears $5,000 and Feb. 18 earnings loom

B2Gold shares rose 0.7% to $5.24 in U.S. trading Friday as spot gold hovered near $5,000 an ounce. The company will release 2025 results and 2026 guidance on Feb. 18. A recent policy shift in Mali, where B2Gold operates, has added risk for miners. Spot silver topped $100 for the first time, according to Reuters.
23 January 2026
·····
Kenvue (KVUE) stock price barely budges as Kimberly-Clark deal vote nears

Kenvue (KVUE) stock price barely budges as Kimberly-Clark deal vote nears

Kenvue shares rose 0.1% to $17.77 Friday as investors await a Jan. 29 shareholder vote on its proposed sale to Kimberly-Clark. The deal would give Kenvue holders $3.50 in cash and 0.14625 Kimberly-Clark shares per Kenvue share. Institutional Shareholder Services recommended approval but cited litigation risks. Trading volume has surged ahead of the vote.
23 January 2026
······
Amphenol stock slips as Wall Street waits for earnings next week

Amphenol stock slips as Wall Street waits for earnings next week

Amphenol shares fell about 0.9% to $151.14 Friday afternoon as investors awaited its quarterly report due January 28. Trading volume was below average, with focus on the integration of the recently acquired CommScope connectivity business. The company expects the deal to boost adjusted profits by 2026. Broader U.S. markets were mixed, with the Dow down and S&P 500 near flat.
23 January 2026
·····
PNC stock price slips as regional banks slide — bond sale and Fed week loom

PNC stock price slips as regional banks slide — bond sale and Fed week loom

PNC shares fell 1.4% to $218.91 by Friday afternoon, tracking a broader 3% drop in regional bank stocks. A filing showed PNC plans to raise $1.5 billion in subordinated notes due 2041 and $1.5 billion in senior notes due 2029. Investors are watching next week’s Federal Reserve meeting and bank guidance on net interest income. First Citizens BancShares shares dropped 8% after warning of weaker net interest income for 2026.
23 January 2026
·····
AbbVie stock rises as India rejects Venetoclax patent bid; ABBV traders eye Feb. 4 earnings

AbbVie stock rises as India rejects Venetoclax patent bid; ABBV traders eye Feb. 4 earnings

AbbVie shares rose 0.6% to $219.33 Friday after India’s patent office rejected the company’s bid to patent blood-cancer drug venetoclax, raising prospects for generics. The Health Care Select Sector SPDR Fund fell 0.6%. Investors are watching for AbbVie’s Feb. 4 earnings after recent guidance cuts and U.S. pricing deals.
23 January 2026
····
Super Micro (SMCI) stock flips lower after early pop as Feb. 3 earnings loom

Super Micro (SMCI) stock flips lower after early pop as Feb. 3 earnings loom

Super Micro Computer shares fell 2.5% to $31.64 Friday, reversing early gains ahead of its Feb. 3 earnings report. The company previously shifted $1.5 billion in revenue to the December quarter due to last-minute GPU rack changes. Super Micro expects second-quarter revenue of $10–11 billion, topping analyst forecasts. Rising component costs and margin pressures remain concerns for investors.
23 January 2026
·····
USB stock falls today as bank sector slides; U.S. Bancorp bond sale and Fed week in focus

USB stock falls today as bank sector slides; U.S. Bancorp bond sale and Fed week in focus

U.S. Bancorp shares fell 1.1% to $55.58 Friday afternoon, tracking a 3% drop in the SPDR S&P Bank ETF as regional banks slid after First Citizens BancShares’ weak outlook. The lender priced $2.25 billion in fixed-to-floating senior notes this week. Investors are focused on next week’s Federal Reserve meeting and its impact on bank margins. Wells Fargo, Bank of America, and JPMorgan also declined in afternoon trading.
23 January 2026
······
1 … 345 346 347 348 349 … 1,918

Stock Market Today

LSEG share price: London Stock Exchange Group stock braces for Monday after AI jitters and buyback move

LSEG share price: London Stock Exchange Group stock braces for Monday after AI jitters and buyback move

7 February 2026
London, Feb 7, 2026, 08:20 GMT — Market closed. London Stock Exchange Group plc (LSEG.L) shares ended Friday at 7,502 pence, down about 1.1% on the day, with London markets shut for the weekend and set to reopen on Monday. (MarketWatch) The stock has been caught in a wider repricing of software, data and analytics names as investors question which business models benefit from the next wave of AI — and which get squeezed. “It’s a de-risking trade,” Andrew Wells, chief investment officer at SanJac Alpha, said, as he argued the AI build-out had become “too pricey.” (Reuters) LSEG also
GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
Go toTop